Answers are grounded in this paper and cite their sources.
Background: We aimed to evaluate the outcomes of laparoscopic splenectomy (LS) in patients with immune thrombocytopenic purpura (ITP) compared with operated for other indications.Methods: Retrospective cohort study of patients who underwent LS in 1998–2017. Group 1 consisted of 256 patients operated for ITP, and Group 2 of 231 operated for other indications. Primary outcome was procedure difficulty. Secondary was perioperative course (30 days of surgery).Results: Patients in Group 1 were younger (p < .001) with lower ASA (p < .001). The spleen was larger in Group 2 (p < .001). Operative time was longer in Group 2 [110 (80–150) vs. 90 (65–115) min; p < .001)]. Intraoperative blood loss was greater in Group 2 (p < .001). Conversions were higher in Group 2 (4.76 vs. 6.93%, p = .037), as were intraoperative complications (7.79 vs. 3.91%, p = .048). Morbidity, reoperations and mortality did not differ between groups (respectively, p = .899, .697, and .999). Median length of stay was similar (p = .211). Among the first 10 LSs performed by trainees, 63.66% were done for ITP. Later (after 11+ procedures) this dropped to 48.12% (p = .002).Conclusions: ITP may be a preferred indication for surgeons training for LS. Patients’ characteristics and intraoperative factors allow an expectation for a relatively easy and hassle-free operation in those patients.
No takes yet. Share an insight, caveat, or question.
Radkowiak et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: